VivoSim Labs (VIVS) Interest Coverage Ratio Growth (3y) (2014 - 2026)
VivoSim Labs (VIVS) Interest Coverage Ratio Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 29.79% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 33.30% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 78.77% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 81.16% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -35.50% |
| 10 | VivoSim Labs | 1.49 Mn | 1.49 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 36.39% |
| Mar 31, 2026 | -134.56% |
| Dec 31, 2025 | 29.01% |
| Sep 30, 2025 | 10.57% |
| Jun 30, 2025 | 6.42% |
| Mar 31, 2025 | 40.88% |
| Dec 31, 2024 | -59.07% |
| Jun 30, 2024 | -94.27% |
| Mar 31, 2024 | -183.50% |
| Dec 31, 2023 | -188.01% |
| Sep 30, 2023 | 14.93% |
| Jun 30, 2023 | 1.80% |
| Dec 31, 2022 | 36.70% |
| Sep 30, 2022 | -69.95% |
| Jun 30, 2022 | -188.71% |
| Dec 31, 2021 | -546.68% |
| Jun 30, 2021 | 27.25% |
| Dec 31, 2020 | 50.38% |
| Sep 30, 2020 | -115.71% |
| Jun 30, 2020 | -122.85% |